Status:
COMPLETED
Low-Molecular-Weight Heparin Injection in Stroke Patients
Lead Sponsor:
Kastamonu University
Conditions:
Stroke
Eligibility:
All Genders
Phase:
NA
Brief Summary
Bruising as a result of heparin injection increases patients' anxiety, decreases their confidence in the effectiveness of nurses and causes them to refuse the injection. This undesirable effect can be...
Detailed Description
Anticoagulants are medicines that prevent blood from clotting as quickly or effectively as normal. Can be administered IV or subcutaneously. The main complications of heparin therapy are bleeding, thr...
Eligibility Criteria
Inclusion
- Patients aged 18 years or older
- Hospitalized in the neurology clinic
- Who were administered at least once a day LMWH via subcutaneous injections in the arm
- Who agreed to participate in the study were included in this study
Exclusion
- Patients who refused to participate in the study
- Patients with an INR value above 1.3 (hospital reference range was taken)
- Patients taking anticoagulant drugs were included in the study
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06076434
Start Date
November 1 2022
End Date
May 15 2023
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kastamonu University
Kastamonu, Turkey (Türkiye)